[Form 4] The Vita Coco Company, Inc. Insider Trading Activity
Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported two sales of common stock under a Rule 10b5-1 plan. The filings show a sale of 1,000 shares on 09/05/2025 at $38.00 and a sale of 1,000 shares on 09/08/2025 at $38.51, reducing his beneficially owned common stock to 41,754 shares. The report also lists outstanding non-qualified stock options exercisable into common stock: 14,205 shares at a $16.91 strike, 13,481 at $24.35, 8,746 at $26.18, 11,547 at $27.59 and 13,218 at $33.36, each held directly. Several option grants have scheduled vesting dates and installment vesting schedules as described by the reporting person.
Corey Baker, Chief Financial Officer di Vita Coco Company, Inc. (COCO), ha comunicato due vendite di azioni ordinarie effettuate nell'ambito di un piano Rule 10b5-1. I documenti riportano la vendita di 1.000 azioni il 05/09/2025 a 38,00$ e di 1.000 azioni l'08/09/2025 a 38,51$, riducendo la sua partecipazione in azioni ordinarie a 41.754 azioni. Il rapporto elenca inoltre opzioni azionarie non qualificate in essere esercitabili in azioni ordinarie: 14.205 azioni a un prezzo di esercizio di 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ e 13.218 a 33,36$, tutte detenute direttamente. Diversi grant di opzioni prevedono date di maturazione e piani di vesting in tranche come specificato dal dichiarante.
Corey Baker, Director Financiero de Vita Coco Company, Inc. (COCO), informó dos ventas de acciones comunes bajo un plan Rule 10b5-1. Las presentaciones muestran la venta de 1.000 acciones el 05/09/2025 a 38,00$ y de 1.000 acciones el 08/09/2025 a 38,51$, reduciendo su participación en acciones comunes a 41.754 acciones. El informe también enumera opciones sobre acciones no calificadas pendientes ejercitables en acciones comunes: 14.205 acciones con un precio de ejercicio de 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ y 13.218 a 33,36$, todas en propiedad directa. Varias concesiones de opciones tienen fechas de adquisición y cronogramas de vesting por cuotas según lo descrito por el informante.
코리 베이�(본사 재무책임�, Vita Coco Company, Inc. (COCO))가 Rule 10b5-1 계획� 따라 보통� � 건을 매도했다� 보고했습니다. 제출서류� 따르� 2025-09-05� 1,000주를 주당 38.00달러�, 2025-09-08� 1,000주를 주당 38.51달러� 매도� 그의 보유 보통주가 41,754�� 감소했습니다. 보고서에� 또한 보통주로 행사 가능한 비적� 스톡옵션� 다음� 같이 기재되어 있습니다: 행사가 16.91달러� 14,205�, 24.35달러� 13,481�, 26.18달러� 8,746�, 27.59달러� 11,547�, 33.36달러� 13,218주로 모두 직접 보유 중입니다. 여러 옵션 부여에� 보고자가 설명� 대� 만기� � 할부� 베스� 일정� 있습니다.
Corey Baker, directeur financier de Vita Coco Company, Inc. (COCO), a déclaré deux ventes d'actions ordinaires dans le cadre d'un plan Rule 10b5-1. Les documents indiquent la vente de 1 000 actions le 05/09/2025 à 38,00$ et de 1 000 actions le 08/09/2025 à 38,51$, réduisant sa détention d'actions ordinaires à 41 754 actions. Le rapport énumère également des options sur actions non qualifiées en instance, exerçables en actions ordinaires : 14 205 actions au prix d'exercice de 16,91$, 13 481 à 24,35$, 8 746 à 26,18$, 11 547 à 27,59$ et 13 218 à 33,36$, toutes détenues directement. Plusieurs attributions d'options comportent des dates d'acquisition et des calendriers de vesting échelonnés, tels que décrits par le déclarant.
Corey Baker, Finanzvorstand von Vita Coco Company, Inc. (COCO), meldete zwei Verkäufe von Stammaktien im Rahmen eines Rule-10b5-1-Plans. Den Unterlagen zufolge wurden am 05.09.2025 1.000 Aktien zu je 38,00$ und am 08.09.2025 1.000 Aktien zu je 38,51$ verkauft, wodurch sein wirtschaftlicher Bestand an Stammaktien auf 41.754 Aktien gesunken ist. Der Bericht listet außerdem noch ausstehende nicht qualifizierte Aktienoptionen, die in Stammaktien ausgeübt werden können: 14.205 Aktien zu einem Ausübungspreis von 16,91$, 13.481 zu 24,35$, 8.746 zu 26,18$, 11.547 zu 27,59$ und 13.218 zu 33,36$, jeweils direkt gehalten. Mehrere Optionszuteilungen sehen Fälligkeitsdaten und Raten- bzw. Staffel-Vesting-Pläne vor, wie vom Berichtenden erläutert.
- Transactions executed under a Rule 10b5-1 plan, indicating pre-established trading instructions and compliance with insider trading protocols
- Detailed option and vesting schedules disclosed, providing transparency about future potential dilution and executive alignment with equity
- Reduction in direct common stock holdings from 42,754 to 41,754 shares following the reported sales
Insights
TL;DR: Routine insider sales under a 10b5-1 plan; no new equity issuance or debt changes reported.
The Form 4 discloses two small open-market sales by the CFO executed pursuant to a pre-established Rule 10b5-1 trading plan, which suggests these transactions follow a predetermined schedule rather than opportunistic timing. The filing confirms continued equity exposure via substantial outstanding options across multiple strike prices and staggered vesting schedules. There is no indication in the filing of additional corporate actions or material changes to capital structure.
TL;DR: Disclosure is compliant and shows typical officer liquidity within a structured trading plan.
The report includes required details: transaction dates, amounts, prices, ownership after sale, and explanatory vesting terms for options. Use of a Rule 10b5-1 plan is explicitly noted, which supports an affirmative defense to insider trading claims so long as plan conditions were met. The attestation by an attorney-in-fact is present. No governance irregularities or departures are disclosed.
Corey Baker, Chief Financial Officer di Vita Coco Company, Inc. (COCO), ha comunicato due vendite di azioni ordinarie effettuate nell'ambito di un piano Rule 10b5-1. I documenti riportano la vendita di 1.000 azioni il 05/09/2025 a 38,00$ e di 1.000 azioni l'08/09/2025 a 38,51$, riducendo la sua partecipazione in azioni ordinarie a 41.754 azioni. Il rapporto elenca inoltre opzioni azionarie non qualificate in essere esercitabili in azioni ordinarie: 14.205 azioni a un prezzo di esercizio di 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ e 13.218 a 33,36$, tutte detenute direttamente. Diversi grant di opzioni prevedono date di maturazione e piani di vesting in tranche come specificato dal dichiarante.
Corey Baker, Director Financiero de Vita Coco Company, Inc. (COCO), informó dos ventas de acciones comunes bajo un plan Rule 10b5-1. Las presentaciones muestran la venta de 1.000 acciones el 05/09/2025 a 38,00$ y de 1.000 acciones el 08/09/2025 a 38,51$, reduciendo su participación en acciones comunes a 41.754 acciones. El informe también enumera opciones sobre acciones no calificadas pendientes ejercitables en acciones comunes: 14.205 acciones con un precio de ejercicio de 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ y 13.218 a 33,36$, todas en propiedad directa. Varias concesiones de opciones tienen fechas de adquisición y cronogramas de vesting por cuotas según lo descrito por el informante.
코리 베이�(본사 재무책임�, Vita Coco Company, Inc. (COCO))가 Rule 10b5-1 계획� 따라 보통� � 건을 매도했다� 보고했습니다. 제출서류� 따르� 2025-09-05� 1,000주를 주당 38.00달러�, 2025-09-08� 1,000주를 주당 38.51달러� 매도� 그의 보유 보통주가 41,754�� 감소했습니다. 보고서에� 또한 보통주로 행사 가능한 비적� 스톡옵션� 다음� 같이 기재되어 있습니다: 행사가 16.91달러� 14,205�, 24.35달러� 13,481�, 26.18달러� 8,746�, 27.59달러� 11,547�, 33.36달러� 13,218주로 모두 직접 보유 중입니다. 여러 옵션 부여에� 보고자가 설명� 대� 만기� � 할부� 베스� 일정� 있습니다.
Corey Baker, directeur financier de Vita Coco Company, Inc. (COCO), a déclaré deux ventes d'actions ordinaires dans le cadre d'un plan Rule 10b5-1. Les documents indiquent la vente de 1 000 actions le 05/09/2025 à 38,00$ et de 1 000 actions le 08/09/2025 à 38,51$, réduisant sa détention d'actions ordinaires à 41 754 actions. Le rapport énumère également des options sur actions non qualifiées en instance, exerçables en actions ordinaires : 14 205 actions au prix d'exercice de 16,91$, 13 481 à 24,35$, 8 746 à 26,18$, 11 547 à 27,59$ et 13 218 à 33,36$, toutes détenues directement. Plusieurs attributions d'options comportent des dates d'acquisition et des calendriers de vesting échelonnés, tels que décrits par le déclarant.
Corey Baker, Finanzvorstand von Vita Coco Company, Inc. (COCO), meldete zwei Verkäufe von Stammaktien im Rahmen eines Rule-10b5-1-Plans. Den Unterlagen zufolge wurden am 05.09.2025 1.000 Aktien zu je 38,00$ und am 08.09.2025 1.000 Aktien zu je 38,51$ verkauft, wodurch sein wirtschaftlicher Bestand an Stammaktien auf 41.754 Aktien gesunken ist. Der Bericht listet außerdem noch ausstehende nicht qualifizierte Aktienoptionen, die in Stammaktien ausgeübt werden können: 14.205 Aktien zu einem Ausübungspreis von 16,91$, 13.481 zu 24,35$, 8.746 zu 26,18$, 11.547 zu 27,59$ und 13.218 zu 33,36$, jeweils direkt gehalten. Mehrere Optionszuteilungen sehen Fälligkeitsdaten und Raten- bzw. Staffel-Vesting-Pläne vor, wie vom Berichtenden erläutert.